Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) has achieved a significant milestone by obtaining Depository Trust Company (DTC) eligibility for its common shares. This approval enables electronic clearing and settlement through DTC, which is expected to simplify trading for U.S. investors and enhance the liquidity of the company's shares. CEO Louis Dron emphasized that DTC eligibility improves access for U.S. investors and brokerage firms by facilitating more efficient electronic clearing and settlement processes.
In a parallel development, Redwood AI has entered into an agreement with InvestorBrandNetwork (IBN) to bolster its market presence. IBN will provide a comprehensive suite of services including market awareness, corporate communications, and digital media support. These services encompass editorial coverage, newsletter distribution, social media engagement, and podcast syndication. The engagement is set to run until September 30, 2026, or until the allocated budget of $114,000 is fully utilized. Notably, no securities will be issued as compensation for these services, underscoring a cash-based arrangement.
Redwood AI leverages advanced artificial intelligence to accelerate research and development in chemistry, with primary applications in drug discovery and development, as well as defense and safety solutions. By combining expertise in chemistry, AI, and manufacturing, the company aims to streamline drug synthesis and scale-up processes. Its platform is designed to enable faster and more efficient development of new therapies and chemistry-driven applications.
The DTC eligibility and IBN engagement are strategic moves to enhance investor accessibility and corporate visibility. For more details on the press release, visit https://ibn.fm/Yga70. Additional information about Redwood AI is available at https://redwoodai.com/.
